The European Medicines Agency (EMA) has granted limited approval to Eli Lilly’s (LLY) new Alzheimer’s drug Kisunla, reversing ...

CIHR Institute of Aging’s scientific director announces new Canadian funding and discusses where the research is headed ...

While more research is needed, including human trials, the results are promising. The drug SW033291 could lead to a new type ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

"Bleeds on the brain due to high blood pressure, or again, vessel damage. And all of these things, they interrupt the oxygen ...